Clinical Trial Update: Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of masitinib in progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Multiple Sclerosis Primary Progressive
• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive | Phase 3 | Status: COMPLETED